SCHEMBL6947627

SCHEMBL6947627

NC1CCN(c2ccc(Cl)cn2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
HTR3E A5X5Y0 1/20 0.53
MEN1 O00255 1/20 0.53
HTR3B O95264 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
ALOX15 P16050 1/20 0.53
TSHR P16473 1/20 0.53
NFKB1 P19838 1/20 0.53
HTR3A P46098 1/20 0.53
HTR3D Q70Z44 1/20 0.53
HTR3C Q8WXA8 1/20 0.53
GPR119 Q8TDV5 1/20 0.52
CNR2 P34972 2/20 0.51
HRH3 Q9Y5N1 1/20 0.49
CKS1B P61024 1/20 0.47
SKP1 P63208 1/20 0.47
SKP2 Q13309 1/20 0.47
DEGS1 O15121 1/20 0.46
PDE10A Q9Y233 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29769016 0.98 KMT2A (0.51) KMT2AHTR3EMEN1HTR3BCYP1A2
Hydrochloric Acid SCHEMBL28555801 0.98 KMT2A (0.51) KMT2AHTR3EMEN1HTR3BCYP1A2
Hydrochloric Acid SCHEMBL1997764 0.98 KMT2A (0.51) KMT2AHTR3EMEN1HTR3BCYP1A2
SCHEMBL1351813 0.90 PTPN11 (0.47) KMT2AHTR3EMEN1HTR3BCYP1A2
SCHEMBL1351815 0.90 PTPN11 (0.47) KMT2AHTR3EMEN1HTR3BCYP1A2
SCHEMBL18754559 0.82 GPR119 (0.49) KMT2AGPR119CNR2HRH3DEGS1
SCHEMBL20124827 0.81 HRH3 (0.54) KMT2AHTR3EMEN1HTR3BCYP1A2
SCHEMBL16695272 0.80 CNR2 (0.73) KMT2ACYP1A2GPR119CNR2DRD2
SCHEMBL14018468 0.79 GPR119 (0.52) KMT2AHTR3EMEN1HTR3BCYP1A2
SCHEMBL6945724 0.79 GPR119 (0.53) KMT2AHTR3EMEN1HTR3BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6649627-B1 N-Substituted with 1- (pyrid-2-yl)-piperidine-4-yl radical; gastrointestinal and psychological disorder treatment; antidiabetic tocolytic, and antidepressant agents; irritable bowel syndrome, glaucoma and dysmenorrhoea SANOFI-SYNTHELABO (FR) 2003-11-18 US disclosed
EP-1087961-B1 PHENOXYLPROPANOLAMINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME SANOFI SYNTHELABO (FR) 2002-08-14 EP disclosed
EP-1087961-A1 PHENOXYLPROPANOLAMINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME SANOFI-SYNTHELABO (FR) 2001-04-04 EP disclosed
WO-1999065895-A1 PHENOXYLPROPANOLAMINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME SANOFI-SYNTHELABO (FR) 1999-12-23 WO disclosed